BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3669778)

  • 1. Osteolytic lesions in idiopathic myelofibrosis.
    Gruber A; Osby E
    Med Oncol Tumor Pharmacother; 1987; 4(2):107-9. PubMed ID: 3669778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Idiopathic myelofibrosis with osteolytic lesions].
    Guitiérrez Martín M; Romero Colás MS; Fuertes Palacio MA; Soler Mantilla H; Gómez Casal F
    Med Clin (Barc); 1984 May; 82(18):825-6. PubMed ID: 6738208
    [No Abstract]   [Full Text] [Related]  

  • 3. Osteolytic bone lesions in a patient with idiopathic myelofibrosis and bronchial carcinoma.
    Clutterbuck DJ; Morrison AE; Ludlam CA
    J Clin Pathol; 1995 Sep; 48(9):867-8. PubMed ID: 7490324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pure osteolytic lesions in myelofibrosis: report of 2 cases].
    Cassi E; De Paoli A; Tosi A; Turri C
    Haematologica; 1985; 70(2):178-83. PubMed ID: 3924784
    [No Abstract]   [Full Text] [Related]  

  • 5. Elevated TNF-alpha and LDH without parathormone disturbance is associated with diffuse osteolytic lesions in leukemic transformation of myelofibrosis.
    Jurisic V; Terzic T; Pavlovic S; Colovic N; Colovic M
    Pathol Res Pract; 2008; 204(2):129-32. PubMed ID: 17976926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloid metaplasia and osteolytic lesions.
    Leimert JT; Armitage JO; Dick FR
    Am J Clin Pathol; 1978 Oct; 70(4):706-8. PubMed ID: 707437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Primary myelofibrosis and osteolytic lesions].
    Poullin P; Gabriel B
    Rev Rhum Ed Fr; 1994; 61(7-8):560-2. PubMed ID: 7833895
    [No Abstract]   [Full Text] [Related]  

  • 8. [Agnogenic myeloid metaplasia. Description of a case characterized by diffuse osteolytic lesions].
    Lucianò S; Finocchi C; Danesi C; Tafi L
    Radiol Med; 1995 Mar; 89(3):334-5. PubMed ID: 7754131
    [No Abstract]   [Full Text] [Related]  

  • 9. Case report 402: Megakaryocytic myelosis with disseminated osteolysis and osteomyelosclerosis.
    Herrera A; Urbanitz D; Rossner A; Lingg G; Grundmann E
    Skeletal Radiol; 1986; 15(8):672-9. PubMed ID: 3810195
    [No Abstract]   [Full Text] [Related]  

  • 10. Involvement of transforming growth factor-beta and thrombopoietin in the pathogenesis of myelodysplastic syndrome with myelofibrosis.
    Akiyama T; Matsunaga T; Terui T; Miyanishi K; Tanaka I; Sato T; Kuroda H; Takimoto R; Takayama T; Kato J; Yamauchi N; Kogawa K; Sakamaki S; Hirayama Y; Kohda K; Niitsu Y
    Leukemia; 2005 Sep; 19(9):1558-66. PubMed ID: 16034467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Osteolytic lesions in idiopathic myelofibrosis: presentation of 2 cases].
    Ribera JM; Bladé J; Cervantes F; Feliu E; Sierra J; Brugués R; Rozman C
    Med Clin (Barc); 1983 Dec; 81(19):861-4. PubMed ID: 6656465
    [No Abstract]   [Full Text] [Related]  

  • 12. Coexistence of myelofibrosis and focal osteolysis with clusters of megakaryocytes and necrosis in a patient with trilineage myelodysplastic syndrome.
    Rebel VI; Huijgens PC; Wijermans PW; van der Valk P; Langenhuijsen MM
    Eur J Haematol; 1991 Aug; 47(2):155-7. PubMed ID: 1889485
    [No Abstract]   [Full Text] [Related]  

  • 13. Problems of differential diagnosis in a case of bone lesions caused by myelosclerosis associated with hyperparathyroidism.
    Moczar E; Somogyi Z; Nagy P; Tenczer J; Szende B; Gráf F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(2):265-77. PubMed ID: 2410335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis of myelofibrosis with myeloid metaplasia: Insight from mouse models.
    Chagraoui H; Wendling F; Vainchenker W
    Best Pract Res Clin Haematol; 2006; 19(3):399-412. PubMed ID: 16781480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-malignant lytic lesions of bone.
    Gaffney EK; Summers G
    Int J Rheum Dis; 2012 Feb; 15(1):e10-1. PubMed ID: 22324959
    [No Abstract]   [Full Text] [Related]  

  • 16. [A case of cutaneous extramedullary hematopoiesis associated with idiopathic myelofibrosis].
    Corella F; Barnadas MA; Bordes R; Curell R; Espinosa I; Vergara C; Alomar A
    Actas Dermosifiliogr; 2008 May; 99(4):297-300. PubMed ID: 18394406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bilateral interstitial pneumonic shadows caused by perivascular fibrosis and extramedullary megakaryopoiesis of the lung in a case of advanced agnogenic myeloid metaplasia and myelofibrosis.
    Ueno H; Yoneda R; Ogawa W; Yoon S; Kitazawa S; Kitazawa R; Kasuga M
    Acta Haematol; 2000; 104(4):212-6. PubMed ID: 11279314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent association of idiopathic myelofibrosis with plasma cell dyscrasias.
    Dührsen U; Uppenkamp M; Meusers P; König E; Brittinger G
    Blut; 1988 Mar; 56(3):97-102. PubMed ID: 3355902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myelofibrosis and acute megakaryoblastic leukemia in a child: topographic relationship between fibroblasts and megakaryocytes with an alpha-granule defect.
    Breton-Gorius J; Bizet M; Reyes F; Dupuy E; Mear C; Vannier JP; Tron P
    Leuk Res; 1982; 6(1):97-110. PubMed ID: 6461801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocytic sarcoma of megakaryoblastic differentiation in the lymph nodes terminating as acute megakaryoblastic leukemia in a case of chronic idiopathic myelofibrosis persisting for 16 years.
    Hirose Y; Masaki Y; Shimoyama K; Sugai S; Nojima T
    Eur J Haematol; 2001 Sep; 67(3):194-8. PubMed ID: 11737254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.